Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26FG3EH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,726
Award facts
- Contract value 100% obligated
- $24,726.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $24,726.12 delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg dose auto-injector pens on January 9, 2026, with final delivery required by January 12, 2026. This is a firm fixed-price, non-set-aside contract with performance at the awardee's facility in Conshohocken, Pennsylvania. The delivery order was issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at up to $999,999,999.00 and extending through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor serving federal medical procurement needs. The company has demonstrated capability to compete successfully for federal contracts on an open basis and supplies critical pharmaceutical commodities including specialty medications, brand-name and generic drugs, and medical devices across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Cosentyx, a biologic immunosuppressant used to treat autoimmune conditions, represents the type of specialized pharmaceutical product routinely procured through the DLA supply chain to support military treatment facilities and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FG3EH?
SPE2DR26FG3EH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26FG3EH worth?
The government has obligated $24,726 on SPE2DR26FG3EH.
Is contract SPE2DR26FG3EH an order under another contract?
Yes. SPE2DR26FG3EH is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG3EH competed?
The extent of competition for SPE2DR26FG3EH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award